Loading stock…

Sabra Health Care REIT, Inc. (SBRA) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated today

Sabra Health Care REIT, Inc.

SBRAMarket cap $4.81BPrice $18.8

Country🇺🇸United States

SectorReal Estate

IndustryHealthcare REITs

Owns and leases senior housing, skilled nursing, and hospital properties across the U.S. and Canada, collecting rent from healthcare operators instead of running facilities itself. Aging Baby Boomers make this a demographic bet disguised as a real estate portfolio.

In Bastion Portfolios?

52W Return+9%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+13%8

Revenue Forecast

Rev CAGR (1y)+19%8

Rev CAGR (3y)+15%8

Rev CAGR (5y)+13%8

Earnings Forecast

EPS Growth Y+1+24%8

EPS Growth Y+2+17%8

EPS Growth Y+3+9%6

Quality

Margins

EBIT Margin19%7

Net Income Margin8%5

Free Cash Flow Margin43%10

Debt

Net Debt/EBITDA6.41

Efficiency

ROE2%2

ROA1%3

Earnings Stability44

GEAR+AVERAGE66

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)253

P/E Ratio (Forward 3y)222

P/BV1.77

EV Multiples

EV/EBITDA Fwd144

EV/EBIT Fwd322

Yield

Free Cash Flow Yieldna–

Dividend Yield6.4%10

Momentum

Short term

1 month return-9%2

3 month return-4%5

YTD return+4%5

Mid term

Price vs 52wHigh84%6

1 year return+12%6

Long term

3 year return+66%6

5 year return+91%7

Risk Shield

Price Risk

Beta0.110

Volatility24%9

Free Cash Flow

Free Cash Flow Margin43%10

Free Cash Flow Yieldna–

Quality

ROCE3%2

Earnings Stability44

Net Debt/EBITDA6.41

02Growth

Is it actually growing, and how fast?

SBRASabra Health Care REIT

Revenue FY25$703M

GROWTH RATING↗

STRONG79 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+13%8

Revenue, next 1Y+19%8

Revenue, next 3Y, CAGR+15%8

Revenue, next 5Y, CAGR+13%8

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+24%8

EPS growth, FY27E+17%8

EPS growth, FY28E+9%6

GROWTH ASSESSMENT

STRENGTHS

It out-grows 79% of companies worldwide.

Revenue grew 13%/yr over the last 3 years, ahead of 70% of companies worldwide.8/10

Revenue is set to grow 15%/yr over the next 3 years, ahead of most of the market.8/10

Revenue grew 13%/yr over the last 3 years and is set to keep growing around 15%/yr.

The runway holds up: revenue is set to grow 13%/yr over five years.8/10

Earnings are set to grow in step with sales (EPS about 17%/yr vs revenue 15%/yr).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE45 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-9%2

3-month return-4%5

YTD return+4%5

MID & LONG-TERM▾SCORE

% of 52-week high84%6

1-year return+12%6

3-year return+66%6

5-year return+91%7

MOMENTUM ASSESSMENT

STRENGTHS

Strong long-term results. Long-term holders have seen +66% over three years and +91% over five, ahead of 60% of the market.

WATCH

It's up 12% over the past year, but 16% below its 52-week high. That is a touch ahead of the market.

Returns sit at the market level over three months (-4%) and so far this year (+4%).

WEAKNESSES

The stock is underperforming over the past month (-9%).

BOTTOM LINE

Steady Compounder

Dependable multi-year returns with a calmer near-term tape. A reliable long-term trend rather than a short-term breakout. The one thing to watch: the stock is underperforming over the past month.

04Value

Are you paying a fair price for it?

Stop guessing on Sabra Health Care REIT, Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

SBRASabra Health Care REIT

Revenue FY25$703M

GROWTH RATING↗

STRONG79 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+13%8

Revenue, next 1Y+19%8

Revenue, next 3Y, CAGR+15%8

Revenue, next 5Y, CAGR+13%8

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+24%8

EPS growth, FY27E+17%8

EPS growth, FY28E+9%6

GROWTH ASSESSMENT

STRENGTHS

It out-grows 79% of companies worldwide.

Revenue grew 13%/yr over the last 3 years, ahead of 70% of companies worldwide.8/10

Revenue is set to grow 15%/yr over the next 3 years, ahead of most of the market.8/10

Revenue grew 13%/yr over the last 3 years and is set to keep growing around 15%/yr.

The runway holds up: revenue is set to grow 13%/yr over five years.8/10

Earnings are set to grow in step with sales (EPS about 17%/yr vs revenue 15%/yr).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE45 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-9%2

3-month return-4%5

YTD return+4%5

MID & LONG-TERM▾SCORE

% of 52-week high84%6

1-year return+12%6

3-year return+66%6

5-year return+91%7

MOMENTUM ASSESSMENT

STRENGTHS

Strong long-term results. Long-term holders have seen +66% over three years and +91% over five, ahead of 60% of the market.

WATCH

It's up 12% over the past year, but 16% below its 52-week high. That is a touch ahead of the market.

Returns sit at the market level over three months (-4%) and so far this year (+4%).

WEAKNESSES

The stock is underperforming over the past month (-9%).

BOTTOM LINE

Steady Compounder

Dependable multi-year returns with a calmer near-term tape. A reliable long-term trend rather than a short-term breakout. The one thing to watch: the stock is underperforming over the past month.

04Value

Are you paying a fair price for it?

Stop guessing on Sabra Health Care REIT, Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community